Pentwater Capital Management’s AbCellera Biologics ABCL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-137,500	Closed	-$1.97M	–	124
2021 Q4	$1.97M	Buy	137,500 +35,000	+34%	+$500K	0.02%	93
2021 Q3	$2.05M	Sell	102,500 -10,000	-9%	-$200K	0.02%	107
2021 Q2	$2.48M	Buy	+112,500	New	+$2.48M	0.02%	113